Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 110

1.

Context-specific regulation of surface and soluble IL7R expression by an autoimmune risk allele.

Al-Mossawi H, Yager N, Taylor CA, Lau E, Danielli S, de Wit J, Gilchrist J, Nassiri I, Mahe EA, Lee W, Rizvi L, Makino S, Cheeseman J, Neville M, Knight JC, Bowness P, Fairfax BP.

Nat Commun. 2019 Oct 8;10(1):4575. doi: 10.1038/s41467-019-12393-1.

2.

A genetics-led approach defines the drug target landscape of 30 immune-related traits.

Fang H; ULTRA-DD Consortium, De Wolf H, Knezevic B, Burnham KL, Osgood J, Sanniti A, Lledó Lara A, Kasela S, De Cesco S, Wegner JK, Handunnetthi L, McCann FE, Chen L, Sekine T, Brennan PE, Marsden BD, Damerell D, O'Callaghan CA, Bountra C, Bowness P, Sundström Y, Milani L, Berg L, Göhlmann HW, Peeters PJ, Fairfax BP, Sundström M, Knight JC.

Nat Genet. 2019 Jul;51(7):1082-1091. doi: 10.1038/s41588-019-0456-1. Epub 2019 Jun 28.

PMID:
31253980
3.

Progress in our understanding of the pathogenesis of ankylosing spondylitis.

Simone D, Al Mossawi MH, Bowness P.

Rheumatology (Oxford). 2018 Aug 1;57(suppl_6):vi4-vi9. doi: 10.1093/rheumatology/key001. Review.

4.

Advancing research paradigms and pathophysiological pathways in psoriatic arthritis and ankylosing spondylitis: Proceedings of the 2017 Platform for the Exchange of Expertise and Research (PEER) meeting.

Abraham S, Barton A, Eder L, Lim A, McGonagle D, McHugh N, Pennington S, Sengupta R, Siebert S, Bowness P, Schafer PH, Cullen E, FitzGerald O.

Semin Arthritis Rheum. 2019 Jun;48(6):1005-1013. doi: 10.1016/j.semarthrit.2018.10.008. Epub 2018 Oct 15. No abstract available.

5.

Salmonella exploits HLA-B27 and host unfolded protein responses to promote intracellular replication.

Antoniou AN, Lenart I, Kriston-Vizi J, Iwawaki T, Turmaine M, McHugh K, Ali S, Blake N, Bowness P, Bajaj-Elliott M, Gould K, Nesbeth D, Powis SJ.

Ann Rheum Dis. 2019 Jan;78(1):74-82. doi: 10.1136/annrheumdis-2018-213532. Epub 2018 Oct 24.

6.

Inhibiting ex-vivo Th17 responses in Ankylosing Spondylitis by targeting Janus kinases.

Hammitzsch A, Chen L, de Wit J, Al-Mossawi MH, Ridley A, Sekine T, Simone D, Doig K, Skapenko A, Bowness P.

Sci Rep. 2018 Oct 23;8(1):15645. doi: 10.1038/s41598-018-34026-1.

7.

Genetic Architecture of Adaptive Immune System Identifies Key Immune Regulators.

Lagou V, Garcia-Perez JE, Smets I, Van Horebeek L, Vandebergh M, Chen L, Mallants K, Prezzemolo T, Hilven K, Humblet-Baron S, Moisse M, Van Damme P, Boeckxstaens G, Bowness P, Dubois B, Dooley J, Liston A, Goris A.

Cell Rep. 2018 Oct 16;25(3):798-810.e6. doi: 10.1016/j.celrep.2018.09.048.

8.

Incidence of Total Hip and Knee Replacement in UK Patients with Ankylosing Spondylitis.

Hawley S, Sacks S, Bowness P, Prieto-Alhambra D.

J Rheumatol. 2018 Aug;45(9):1334-1336. doi: 10.3899/jrheum.171387. No abstract available.

PMID:
30173183
9.

Novel Therapeutic Targets in Axial Spondyloarthritis.

Worth C, Bowness P, Hussein Al-Mossawi M.

Curr Treatm Opt Rheumatol. 2018;4(2):174-182. doi: 10.1007/s40674-018-0095-1. Epub 2018 Apr 12. Review.

10.

Evidence for a second ankylosing spondylitis-associated RUNX3 regulatory polymorphism.

Vecellio M, Cortes A, Roberts AR, Ellis J, Cohen CJ, Knight JC, Brown MA, Bowness P, Wordsworth BP.

RMD Open. 2018 Feb 8;4(1):e000628. doi: 10.1136/rmdopen-2017-000628. eCollection 2018.

11.

Unique transcriptome signatures and GM-CSF expression in lymphocytes from patients with spondyloarthritis.

Al-Mossawi MH, Chen L, Fang H, Ridley A, de Wit J, Yager N, Hammitzsch A, Pulyakhina I, Fairfax BP, Simone D, Yi Y, Bandyopadhyay S, Doig K, Gundle R, Kendrick B, Powrie F, Knight JC, Bowness P.

Nat Commun. 2017 Nov 15;8(1):1510. doi: 10.1038/s41467-017-01771-2.

12.

Is Behçet's disease a 'class 1-opathy'? The role of HLA-B*51 in the pathogenesis of Behçet's disease.

Giza M, Koftori D, Chen L, Bowness P.

Clin Exp Immunol. 2018 Jan;191(1):11-18. doi: 10.1111/cei.13049. Epub 2017 Oct 6. Review. Erratum in: Clin Exp Immunol. 2018 Mar;191(3):373.

13.

A biallelic mutation in IL6ST encoding the GP130 co-receptor causes immunodeficiency and craniosynostosis.

Schwerd T, Twigg SRF, Aschenbrenner D, Manrique S, Miller KA, Taylor IB, Capitani M, McGowan SJ, Sweeney E, Weber A, Chen L, Bowness P, Riordan A, Cant A, Freeman AF, Milner JD, Holland SM, Frede N, Müller M, Schmidt-Arras D, Grimbacher B, Wall SA, Jones EY, Wilkie AOM, Uhlig HH.

J Exp Med. 2017 Sep 4;214(9):2547-2562. doi: 10.1084/jem.20161810. Epub 2017 Jul 26.

14.

miR-10b-5p is a novel Th17 regulator present in Th17 cells from ankylosing spondylitis.

Chen L, Al-Mossawi MH, Ridley A, Sekine T, Hammitzsch A, de Wit J, Simone D, Shi H, Penkava F, Kurowska-Stolarska M, Pulyakhina I, Knight JC, Kim TJ, Bowness P.

Ann Rheum Dis. 2017 Mar;76(3):620-625. doi: 10.1136/annrheumdis-2016-210175. Epub 2016 Dec 30.

PMID:
28039186
15.

Polymorphisms in the F Pocket of HLA-B27 Subtypes Strongly Affect Assembly, Chaperone Interactions, and Heavy-Chain Misfolding.

Guiliano DB, North H, Panayoitou E, Campbell EC, McHugh K, Cooke FG, Silvestre M, Bowness P, Powis SJ, Antoniou AN.

Arthritis Rheumatol. 2017 Mar;69(3):610-621. doi: 10.1002/art.39948.

16.

Data showing non-conventional HLA-B27 expression in axial joints and gut tissue from B27 transgenic rats, and in frozen and paraffin-fixed synovial SpA tissue.

Rysnik O, McHugh K, van Duivenvoorde L, van Tok M, Taurog J, Kollnberger S, Baeten D, Bowness P.

Data Brief. 2016 Aug 28;9:100-11. doi: 10.1016/j.dib.2016.08.046. eCollection 2016 Dec.

17.

Position 97 of HLA-B, a residue implicated in pathogenesis of ankylosing spondylitis, plays a key role in cell surface free heavy chain expression.

Chen L, Shi H, Yuan J, Bowness P.

Ann Rheum Dis. 2017 Mar;76(3):593-601. doi: 10.1136/annrheumdis-2016-209512. Epub 2016 Aug 11.

PMID:
27515058
18.

Non-conventional forms of HLA-B27 are expressed in spondyloarthritis joints and gut tissue.

Rysnik O, McHugh K, van Duivenvoorde L, van Tok M, Guggino G, Taurog J, Kollnberger S, Ciccia F, Baeten D, Bowness P.

J Autoimmun. 2016 Jun;70:12-21. doi: 10.1016/j.jaut.2016.03.009. Epub 2016 Mar 29.

19.

An ankylosing spondylitis-associated genetic variant in the IL23R-IL12RB2 intergenic region modulates enhancer activity and is associated with increased Th1-cell differentiation.

Roberts AR, Vecellio M, Chen L, Ridley A, Cortes A, Knight JC, Bowness P, Cohen CJ, Wordsworth BP.

Ann Rheum Dis. 2016 Dec;75(12):2150-2156. doi: 10.1136/annrheumdis-2015-208640. Epub 2016 Feb 25.

20.

Activation-Induced Killer Cell Immunoglobulin-like Receptor 3DL2 Binding to HLA-B27 Licenses Pathogenic T Cell Differentiation in Spondyloarthritis.

Ridley A, Hatano H, Wong-Baeza I, Shaw J, Matthews KK, Al-Mossawi H, Ladell K, Price DA, Bowness P, Kollnberger S.

Arthritis Rheumatol. 2016 Apr;68(4):901-14. doi: 10.1002/art.39515.

21.

RORγt inhibitors suppress T(H)17 responses in inflammatory arthritis and inflammatory bowel disease.

de Wit J, Al-Mossawi MH, Hühn MH, Arancibia-Cárcamo CV, Doig K, Kendrick B, Gundle R, Taylor P, Mcclanahan T, Murphy E, Zhang H, Barr K, Miller JR, Hu X, Aicher TD, Morgan RW, Glick GD, Zaller D, Correll C, Powrie F, Bowness P.

J Allergy Clin Immunol. 2016 Mar;137(3):960-3. doi: 10.1016/j.jaci.2015.09.048. Epub 2015 Nov 21. No abstract available.

PMID:
26611672
22.

The genetic association of RUNX3 with ankylosing spondylitis can be explained by allele-specific effects on IRF4 recruitment that alter gene expression.

Vecellio M, Roberts AR, Cohen CJ, Cortes A, Knight JC, Bowness P, Wordsworth BP.

Ann Rheum Dis. 2016 Aug;75(8):1534-40. doi: 10.1136/annrheumdis-2015-207490. Epub 2015 Oct 9.

23.

CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses.

Hammitzsch A, Tallant C, Fedorov O, O'Mahony A, Brennan PE, Hay DA, Martinez FO, Al-Mossawi MH, de Wit J, Vecellio M, Wells C, Wordsworth P, Müller S, Knapp S, Bowness P.

Proc Natl Acad Sci U S A. 2015 Aug 25;112(34):10768-73. doi: 10.1073/pnas.1501956112. Epub 2015 Aug 10.

24.

Silencing or inhibition of endoplasmic reticulum aminopeptidase 1 (ERAP1) suppresses free heavy chain expression and Th17 responses in ankylosing spondylitis.

Chen L, Ridley A, Hammitzsch A, Al-Mossawi MH, Bunting H, Georgiadis D, Chan A, Kollnberger S, Bowness P.

Ann Rheum Dis. 2016 May;75(5):916-23. doi: 10.1136/annrheumdis-2014-206996. Epub 2015 Jun 30.

25.

HLA-B27-Homodimer-Specific Antibody Modulates the Expansion of Pro-Inflammatory T-Cells in HLA-B27 Transgenic Rats.

Marroquin Belaunzaran O, Kleber S, Schauer S, Hausmann M, Nicholls F, Van den Broek M, Payeli S, Ciurea A, Milling S, Stenner F, Shaw J, Kollnberger S, Bowness P, Petrausch U, Renner C.

PLoS One. 2015 Jun 30;10(6):e0130811. doi: 10.1371/journal.pone.0130811. eCollection 2015.

26.

The interleukin (IL)-23/IL-17 axis in ankylosing spondylitis: new advances and potentials for treatment.

Jethwa H, Bowness P.

Clin Exp Immunol. 2016 Jan;183(1):30-6. doi: 10.1111/cei.12670. Epub 2015 Sep 30. Review.

27.

Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1.

Cortes A, Pulit SL, Leo PJ, Pointon JJ, Robinson PC, Weisman MH, Ward M, Gensler LS, Zhou X, Garchon HJ, Chiocchia G, Nossent J, Lie BA, Førre Ø, Tuomilehto J, Laiho K, Bradbury LA, Elewaut D, Burgos-Vargas R, Stebbings S, Appleton L, Farrah C, Lau J, Haroon N, Mulero J, Blanco FJ, Gonzalez-Gay MA, Lopez-Larrea C, Bowness P, Gaffney K, Gaston H, Gladman DD, Rahman P, Maksymowych WP, Crusius JB, van der Horst-Bruinsma IE, Valle-Oñate R, Romero-Sánchez C, Hansen IM, Pimentel-Santos FM, Inman RD, Martin J, Breban M, Wordsworth BP, Reveille JD, Evans DM, de Bakker PI, Brown MA.

Nat Commun. 2015 May 21;6:7146. doi: 10.1038/ncomms8146.

28.

ERAP2 is associated with ankylosing spondylitis in HLA-B27-positive and HLA-B27-negative patients.

Robinson PC, Costello ME, Leo P, Bradbury LA, Hollis K, Cortes A, Lee S, Joo KB, Shim SC, Weisman M, Ward M, Zhou X, Garchon HJ, Chiocchia G, Nossent J, Lie BA, Førre Ø, Tuomilehto J, Laiho K, Jiang L, Liu Y, Wu X, Elewaut D, Burgos-Vargas R, Gensler LS, Stebbings S, Haroon N, Mulero J, Fernandez-Sueiro JL, Gonzalez-Gay MA, Lopez-Larrea C, Bowness P, Gafney K, Gaston JS, Gladman DD, Rahman P, Maksymowych WP, Xu H, van der Horst-Bruinsma IE, Chou CT, Valle-Oñate R, Romero-Sánchez MC, Hansen IM, Pimentel-Santos FM, Inman RD, Martin J, Breban M, Evans D, Reveille JD, Kim TH, Wordsworth BP, Brown MA.

Ann Rheum Dis. 2015 Aug;74(8):1627-9. doi: 10.1136/annrheumdis-2015-207416. Epub 2015 Apr 27. No abstract available.

29.

HLA-B27.

Bowness P.

Annu Rev Immunol. 2015;33:29-48. doi: 10.1146/annurev-immunol-032414-112110. Review.

PMID:
25861975
30.

Ankylosing spondylitis confers substantially increased risk of clinical spine fractures: a nationwide case-control study.

Prieto-Alhambra D, Muñoz-Ortego J, De Vries F, Vosse D, Arden NK, Bowness P, Cooper C, Diez-Perez A, Vestergaard P.

Osteoporos Int. 2015 Jan;26(1):85-91. doi: 10.1007/s00198-014-2939-3. Epub 2014 Oct 24.

PMID:
25341971
31.

Critical role of endoplasmic reticulum aminopeptidase 1 in determining the length and sequence of peptides bound and presented by HLA-B27.

Chen L, Fischer R, Peng Y, Reeves E, McHugh K, Ternette N, Hanke T, Dong T, Elliott T, Shastri N, Kollnberger S, James E, Kessler B, Bowness P.

Arthritis Rheumatol. 2014 Feb;66(2):284-94. doi: 10.1002/art.38249.

32.

Two birds with one stone: doing metabolomics with your proteomics kit.

Fischer R, Bowness P, Kessler BM.

Proteomics. 2013 Dec;13(23-24):3371-86. doi: 10.1002/pmic.201300192. Epub 2013 Nov 21. Review.

33.

The arthritis-associated HLA-B*27:05 allele forms more cell surface B27 dimer and free heavy chain ligands for KIR3DL2 than HLA-B*27:09.

Cauli A, Shaw J, Giles J, Hatano H, Rysnik O, Payeli S, McHugh K, Dessole G, Porru G, Desogus E, Fiedler S, Hölper S, Carette A, Blanco-Gelaz MA, Vacca A, Piga M, Ibba V, Garau P, La Nasa G, López-Larrea C, Mathieu A, Renner C, Bowness P, Kollnberger S.

Rheumatology (Oxford). 2013 Nov;52(11):1952-62. doi: 10.1093/rheumatology/ket219. Epub 2013 Jun 26.

34.

Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci.

International Genetics of Ankylosing Spondylitis Consortium (IGAS), Cortes A, Hadler J, Pointon JP, Robinson PC, Karaderi T, Leo P, Cremin K, Pryce K, Harris J, Lee S, Joo KB, Shim SC, Weisman M, Ward M, Zhou X, Garchon HJ, Chiocchia G, Nossent J, Lie BA, Førre Ø, Tuomilehto J, Laiho K, Jiang L, Liu Y, Wu X, Bradbury LA, Elewaut D, Burgos-Vargas R, Stebbings S, Appleton L, Farrah C, Lau J, Kenna TJ, Haroon N, Ferreira MA, Yang J, Mulero J, Fernandez-Sueiro JL, Gonzalez-Gay MA, Lopez-Larrea C, Deloukas P, Donnelly P; Australo-Anglo-American Spondyloarthritis Consortium (TASC); Groupe Française d'Etude Génétique des Spondylarthrites (GFEGS); Nord-Trøndelag Health Study (HUNT); Spondyloarthritis Research Consortium of Canada (SPARCC); Wellcome Trust Case Control Consortium 2 (WTCCC2), Bowness P, Gafney K, Gaston H, Gladman DD, Rahman P, Maksymowych WP, Xu H, Crusius JB, van der Horst-Bruinsma IE, Chou CT, Valle-Oñate R, Romero-Sánchez C, Hansen IM, Pimentel-Santos FM, Inman RD, Videm V, Martin J, Breban M, Reveille JD, Evans DM, Kim TH, Wordsworth BP, Brown MA.

Nat Genet. 2013 Jul;45(7):730-8. doi: 10.1038/ng.2667. Epub 2013 Jun 9.

35.

The role of natural killer cells, gamma delta T-cells and other innate immune cells in spondyloarthritis.

Al-Mossawi MH, Ridley A, Kiedel S, Bowness P.

Curr Opin Rheumatol. 2013 Jul;25(4):434-9. doi: 10.1097/BOR.0b013e3283620163. Review.

PMID:
23656711
36.

Expression of aberrant HLA-B27 molecules is dependent on B27 dosage and peptide supply.

McHugh K, Rysnik O, Kollnberger S, Shaw J, Utriainen L, Al-Mossawi MH, Payeli S, Belaunzaran OM, Milling S, Renner C, Bowness P.

Ann Rheum Dis. 2014 Apr;73(4):763-70. doi: 10.1136/annrheumdis-2012-203080. Epub 2013 Apr 26. Erratum in: Ann Rheum Dis. 2016 Jun;75(6):1254.

PMID:
23625978
37.

KIR3DL2 binds to HLA-B27 dimers and free H chains more strongly than other HLA class I and promotes the expansion of T cells in ankylosing spondylitis.

Wong-Baeza I, Ridley A, Shaw J, Hatano H, Rysnik O, McHugh K, Piper C, Brackenbridge S, Fernandes R, Chan A, Bowness P, Kollnberger S.

J Immunol. 2013 Apr 1;190(7):3216-24. doi: 10.4049/jimmunol.1202926. Epub 2013 Feb 25.

38.

Evolution of CD8+ T cell responses after acute PARV4 infection.

Simmons R, Sharp C, Levine J, Bowness P, Simmonds P, Cox A, Klenerman P.

J Virol. 2013 Mar;87(6):3087-96. doi: 10.1128/JVI.02793-12. Epub 2013 Jan 2.

39.

Rapid antigen processing and presentation of a protective and immunodominant HLA-B*27-restricted hepatitis C virus-specific CD8+ T-cell epitope.

Schmidt J, Iversen AK, Tenzer S, Gostick E, Price DA, Lohmann V, Distler U, Bowness P, Schild H, Blum HE, Klenerman P, Neumann-Haefelin C, Thimme R.

PLoS Pathog. 2012;8(11):e1003042. doi: 10.1371/journal.ppat.1003042. Epub 2012 Nov 29.

40.

The phenotype of circulating follicular-helper T cells in patients with rheumatoid arthritis defines CD200 as a potential therapeutic target.

Chakera A, Bennett SC, Morteau O, Bowness P, Luqmani RA, Cornall RJ.

Clin Dev Immunol. 2012;2012:948218. doi: 10.1155/2012/948218. Epub 2012 Oct 4.

41.

HLA-B27 homodimers and free H chains are stronger ligands for leukocyte Ig-like receptor B2 than classical HLA class I.

Giles J, Shaw J, Piper C, Wong-Baeza I, McHugh K, Ridley A, Li D, Lenart I, Antoniou AN, DiGleria K, Kuroki K, Maenaka K, Bowness P, Kollnberger S.

J Immunol. 2012 Jun 15;188(12):6184-93. doi: 10.4049/jimmunol.1102711. Epub 2012 May 16.

42.

Inhibiting HLA-B27 homodimer-driven immune cell inflammation in spondylarthritis.

Payeli SK, Kollnberger S, Marroquin Belaunzaran O, Thiel M, McHugh K, Giles J, Shaw J, Kleber S, Ridley A, Wong-Baeza I, Keidel S, Kuroki K, Maenaka K, Wadle A, Renner C, Bowness P.

Arthritis Rheum. 2012 Oct;64(10):3139-49. doi: 10.1002/art.34538.

43.

The link between HLA-B27 and SpA--new ideas on an old problem.

McHugh K, Bowness P.

Rheumatology (Oxford). 2012 Sep;51(9):1529-39. doi: 10.1093/rheumatology/kes061. Epub 2012 Apr 17. Review.

PMID:
22513152
44.

Parvovirus 4 infection and clinical outcome in high-risk populations.

Simmons R, Sharp C, McClure CP, Rohrbach J, Kovari H, Frangou E, Simmonds P, Irving W, Rauch A, Bowness P, Klenerman P; Swiss HIV Cohort Study.

J Infect Dis. 2012 Jun 15;205(12):1816-20. doi: 10.1093/infdis/jis291. Epub 2012 Apr 5.

45.

Detection of multiple autoantibodies in patients with ankylosing spondylitis using nucleic acid programmable protein arrays.

Wright C, Sibani S, Trudgian D, Fischer R, Kessler B, LaBaer J, Bowness P.

Mol Cell Proteomics. 2012 Feb;11(2):M9.00384. doi: 10.1074/mcp.M9.00384.

46.

Discovery of candidate serum proteomic and metabolomic biomarkers in ankylosing spondylitis.

Fischer R, Trudgian DC, Wright C, Thomas G, Bradbury LA, Brown MA, Bowness P, Kessler BM.

Mol Cell Proteomics. 2012 Feb;11(2):M111.013904. doi: 10.1074/mcp.M111.013904. Epub 2011 Oct 13.

47.

Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility.

Evans DM, Spencer CC, Pointon JJ, Su Z, Harvey D, Kochan G, Oppermann U, Dilthey A, Pirinen M, Stone MA, Appleton L, Moutsianas L, Leslie S, Wordsworth T, Kenna TJ, Karaderi T, Thomas GP, Ward MM, Weisman MH, Farrar C, Bradbury LA, Danoy P, Inman RD, Maksymowych W, Gladman D, Rahman P; Spondyloarthritis Research Consortium of Canada (SPARCC), Morgan A, Marzo-Ortega H, Bowness P, Gaffney K, Gaston JS, Smith M, Bruges-Armas J, Couto AR, Sorrentino R, Paladini F, Ferreira MA, Xu H, Liu Y, Jiang L, Lopez-Larrea C, Díaz-Peña R, López-Vázquez A, Zayats T, Band G, Bellenguez C, Blackburn H, Blackwell JM, Bramon E, Bumpstead SJ, Casas JP, Corvin A, Craddock N, Deloukas P, Dronov S, Duncanson A, Edkins S, Freeman C, Gillman M, Gray E, Gwilliam R, Hammond N, Hunt SE, Jankowski J, Jayakumar A, Langford C, Liddle J, Markus HS, Mathew CG, McCann OT, McCarthy MI, Palmer CN, Peltonen L, Plomin R, Potter SC, Rautanen A, Ravindrarajah R, Ricketts M, Samani N, Sawcer SJ, Strange A, Trembath RC, Viswanathan AC, Waller M, Weston P, Whittaker P, Widaa S, Wood NW, McVean G, Reveille JD, Wordsworth BP, Brown MA, Donnelly P; Australo-Anglo-American Spondyloarthritis Consortium (TASC); Wellcome Trust Case Control Consortium 2 (WTCCC2).

Nat Genet. 2011 Jul 10;43(8):761-7. doi: 10.1038/ng.873. Erratum in: Nat Genet. 2011 Sep;43(9):919. Opperman, Udo [corrected to Oppermann, Udo]; Moutsianis, Loukas [corrected to Moutsianas, Loukas].

48.

Crystal structures of the endoplasmic reticulum aminopeptidase-1 (ERAP1) reveal the molecular basis for N-terminal peptide trimming.

Kochan G, Krojer T, Harvey D, Fischer R, Chen L, Vollmar M, von Delft F, Kavanagh KL, Brown MA, Bowness P, Wordsworth P, Kessler BM, Oppermann U.

Proc Natl Acad Sci U S A. 2011 May 10;108(19):7745-50. doi: 10.1073/pnas.1101262108. Epub 2011 Apr 20.

49.

High frequency, sustained T cell responses to PARV4 suggest viral persistence in vivo.

Simmons R, Sharp C, Sims S, Kloverpris H, Goulder P, Simmonds P, Bowness P, Klenerman P.

J Infect Dis. 2011 May 15;203(10):1378-87. doi: 10.1093/infdis/jir036.

50.

Th17 cells expressing KIR3DL2+ and responsive to HLA-B27 homodimers are increased in ankylosing spondylitis.

Bowness P, Ridley A, Shaw J, Chan AT, Wong-Baeza I, Fleming M, Cummings F, McMichael A, Kollnberger S.

J Immunol. 2011 Feb 15;186(4):2672-80. doi: 10.4049/jimmunol.1002653. Epub 2011 Jan 19.

Supplemental Content

Loading ...
Support Center